Sertindole
|
|
Missing image
Sertindole.png
chemical structure of sertindole
Sertindole.png
chemical structure of sertindole
Sertindole (brand names: Serlect®, Serdolect®) is one of the newer antipsychotic medications to hit the market. Like the other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative.
Sertindole was withdrawn from the market on December 2, 1998 due to concerns over the risk of cardiac arrhythmia and sudden death.
External link
- Important safety message: Serdolect (sertindole) (http://www.open.gov.uk/mca/ourwork/monitorsafequalmed/safetymessages/serdolect2.htm) - suspension of marketing authorisation following EC decision